SIM
CTMX icon

Spark Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Spark Investment Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,100
Closed -$125K – 58
2020
Q2 		$125K Sell
15,100
-161,893
-91% -$1.5M 0.46% 43
2020
Q1 		$1.36M Sell
176,993
-26,607
-13% -$186K 0.72% 33
2019
Q4 		$1.69M Sell
203,600
-133,564
-40% -$901K 0.2% 154
2019
Q3 		$2.49M Sell
337,164
-95,817
-22% -$945K 0.32% 102
2019
Q2 		$4.86M Hold
432,981
– – 0.34% 94
2019
Q1 		$4.65M Buy
432,981
+222,381
+106% +$3.29M 0.22% 130
2018
Q4 		$3.18M Sell
210,600
-13,900
-6% -$206K 0.22% 136
2018
Q3 		$4.15M Sell
224,500
-22,600
-9% -$515K 0.24% 135
2018
Q2 		$5.65M Sell
247,100
-43,600
-15% -$1.11M 0.33% 90
2018
Q1 		$8.27M Buy
290,700
+53,800
+23% +$1.54M 0.53% 44
2017
Q4 		$5M Hold
236,900
– – 0.27% 111
2017
Q3 		$4.3M Hold
236,900
– – 0.23% 154
2017
Q2 		$3.67M Buy
236,900
+135,200
+133% +$2.04M 0.23% 149
2017
Q1 		$1.76M Buy
101,700
+35,000
+52% +$461K 0.11% 273
2016
Q4 		$733K Buy
66,700
+42,796
+179% +$519K 0.06% 400
2016
Q3 		$374K Buy
+23,904
New +$289K 0.03% 542
2016
Q2 		– Sell
-30,900
Closed -$398K – 795
2016
Q1 		$398K Buy
+30,900
New +$429K 0.04% 495

Other funds holding CTMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spark Investment Management's CTMX Position: Q3 2020 in Review

Spark Investment Management sold out of CytomX Therapeutics (CTMX) in Q3 2020, closing a stake of 15,100 shares — an estimated $125K sold.

Spark Investment Management first reported a position in CTMX in Q1 2016 and held it in 17 quarters. The position peaked at $8.27M in Q1 2018. 130 funds tracked by Wall St. Rank hold CTMX as of Q3 2020.

  • Spark Investment Management reported no remaining CytomX Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Spark Investment Management sold 15,100 CytomX Therapeutics shares in Q3 2020, an estimated $125K.
  • Spark Investment Management first reported a position in CytomX Therapeutics in Q1 2016 and held it in 17 quarters.
  • Spark Investment Management's CytomX Therapeutics position peaked at $8.27M in Q1 2018.
  • 130 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2020.

Based on Spark Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.